Regen BioPharma Inc (OTCPK:RGBP)
$ 1.01 -0.09 (-8.18%) Market Cap: 4.16 Mil Enterprise Value: 5.14 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 39/100

Regen BioPharma Inc At Emerging Growth Conference Transcript

Aug 10, 2023 / 03:25PM GMT
Release Date Price: $1.85 (+19.35%)
Ana Berry
Berry Media, Inc - Moderator

Welcome back, everyone. Next, we have Regen Biopharma, Inc. It trades on the OTC Pink Sheets under the symbol RGBP and is a biotechnology company focused on developing innovative treatments using autologous cell therapies, RNA, DNA-based immunotherapy, and small molecules in the immune oncology and autoimmune disease space.

Please welcome, President and CEO, David Koos; as well as Harry Lander, Senior Scientific Consultant. Nice to see you, gentlemen.

David Koos
Regen BioPharma, Inc. - President & CEO

Good morning. We're glad to be here this morning, and I'm excited about finally being able to talk about what's going on with the company.

Ana Berry
Berry Media, Inc - Moderator

Perfect. Well, the floor is yours. And you know to call me back when you're ready for questions.

David Koos
Regen BioPharma, Inc. - President & CEO

Perfect. So I would like to start off this morning, over the last -- I don't know, four

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot